May 2026
The global active pharmaceutical ingredients CDMO market size is evaluated at USD 116.77 billion in 2025 and is predicted to hit around USD 231.48 billion by 2035, growing at a CAGR of 7.81%.
September 2026
The high potency active pharmaceutical ingredients market size is estimated to surpass around USD 68.88 billion by 2035 from USD 33.46 billion in 2026 with a CAGR of 8.37%.
September 2026
The U.S active pharmaceutical ingredients market size stood at USD 44.46 billion in 2026, with major U.S active pharmaceutical ingredients market companies including AbbVie Inc, Viatris Inc, Fresenius Kabi AG.
September 2026
The active pharmaceutical ingredients market size was estimated at USD 252.16 billion in 2026 and is projected to hit around USD 425.26 billion by 2035 with a CAGR of 5.95%.
September 2026
Europe Pharmaceutical CDMO market size is projected to hit around USD 94.94 billion by 2035, rising from USD 49.06 billion in 2026, growing at a CAGR of 7.59%.
September 2026
The global bioactive ingredients market size is calculated at USD 58.49 billion in 2026 and is projected to hit around USD 111.41 billion by 2035 with a CAGR of 7.41%.
June 2026
The global pharmaceutical CDMO for formulations market size is accounted to hit around USD 103.33 billion by 2035, increasing from USD 48.85 billion in 2025, with a CAGR of 7.78%.
March 2026
The global pharmaceutical CDMO market size is calculated at USD 197.40 billion in 2025 and is projected to hit around USD 392.67 billion by 2035 with a CAGR of 7.12%.
January 2026
The global radiopharmaceutical CDMO market size was evaluated at USD 3.24 billion in 2025 and is predicted to hit around USD 8.50 billion by 2035, growing at a CAGR of 10.12%.
August 2025
The U.S. pharmaceutical CDMO market size was calculated at USD 40.52 billion in 2024 and is predicted to reach around USD 83.25 billion by 2034, with a CAGR of 7.47%.
September 2026
The global pharmaceutical capsule filling machines market is growing as demand rises for efficient, high-speed production of oral solid dosage forms.
September 2026
The global pharmaceutical drug delivery market size was calculated at USD 2.17 trillion in 2026 and is projected to hit around USD 3.32 trillion by 2035 with a CAGR of 4.84%.
September 2026
The global automotive active safety systems market size is expected to be worth around USD 297.97 billion by 2035 from USD 138.72 Bn in 2026 with a CAGR of 8.88%.
September 2026
The pharmaceutical contract manufacturing and research services market size is estimated to hit around USD 525.32 billion by 2035, increasing from USD 282.99 billion in 2026, with a CAGR of 7.11%.
September 2026
The interactive wound dressing market size accounted for USD 5.56 billion in 2026 and is expected to hit around USD 8.78 billion by 2035 with a CAGR of 5.20%.
September 2026
The global veterinary CRO and CDMO market size was valued at USD 8.38 billion in 2026 and is predicted to surpass around USD 17.15 billion by 2035 with a CAGR of 8.30%.
September 2026
The global cannabis pharmaceuticals market size is projected to surpass around USD 1,439.34 billion by 2035 from USD 24.34 billion in 2026 with a CAGR of 57.75%.
September 2026
The global anti-aging ingredients market size is evaluated at USD 11.93 billion in 2026 and is predicted to attain around USD 20.26 billion by 2035, with a CAGR of 6.07%.
September 2026
The global graves disease (overactive thyroid) market size is estimated to hit around USD 3.69 billion by 2035 increasing from USD 2.37 billion in 2026, with a CAGR of 5.02%.
September 2026
The pharmaceutical intermediates market is valued at USD 38.90 billion in 2026 and is expected to hit around USD 59.70 billion by 2035, growing at a CAGR of 4.89% from 2026 to 2035.
September 2026
The global biopharmaceuticals market size was valued at USD 616.02 billion in 2026 and is projected to hit around USD 1,983.73 billion by 2035 with a CAGR of 13.95%.
September 2026
The global biopharmaceutical third party logistics market size was valued at USD 162.98 billion in 2026 and is expected to hit around USD 287.89 billion by 2035, growing at a CAGR of 6.53%
September 2026
The global radiopharmaceuticals market size was valued at USD 8.28 billion in 2026 and is expected to hit around USD 15.21 billion by 2035, growing at a CAGR of 7.31%.
September 2026
The global artificial intelligence (AI) in biopharmaceutical market size is projected to hit around USD 29.78 billion by 2035 from USD 1.99 billion in 2025 with a CAGR of 31.07%.
September 2026
The soy protein ingredients market generated USD 7.36 billion in 2026, with prominent soy protein ingredients companies including Archer Daniels Midland Company, The Scoular Company.
September 2026
The global generic pharmaceuticals contract manufacturing market size is projected to hit around USD 135.36 billion by 2034 from USD 85.96 billion in 2026 with a CAGR of 5.84%.
September 2026
The global live biotherapeutic products and microbiome CDMO market size is estimated to hit around USD 1,838.56 million by 2035 from USD 106.79 million in 2026, at a CAGR of 37.38%.
September 2026
The LNP CDMO market reached USD 271.03 million in 2026, featuring leading LNP CDMO market companies such as Lonza Group, WuXi AppTec, Samsung Biologics.
September 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
September 2026
The global pharmaceutical analytical testing market size is expected to hit around USD 22.60 billion by 2035 from USD 10.76 billion in 2026 , with a CAGR of 8.62%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com